Johnson & Johnson vaccine implementation study in South Africa gets regulator nod


South Africa’s drugs regulator SAHPRA said on Monday it has approved an implementation study of Johnson & Johnson’s COVID-19 vaccine but was still reviewing its full market application.



The implementation study will target inoculating between 350,000 to 500,000 health care workers, with the first batch of 80,000 doses expected to arrive this week, President Ramaphosa told lawmakers on Thursday.


The South African Health Products Regulatory Authority (SAHPRA) said J&J has not yet submitted an application for emergency use authorisation of its vaccine, as Africa’s worst hit country with coronavirus infections and deaths has yet to start its mass inoculation campaign.


Written by PH

Leave a Reply

Your email address will not be published. Required fields are marked *


Dominic Ongwen Claims ‘Mental Disability’ In His ICC Verdict’s Appeal

Africa CDC To Deploy Emergency Response Team In Guinea Amid New Ebola Outbreak